Results 21 to 30 of about 12,043,843 (293)

Adherence to Antihypertensive Treatment and Associated Factors in Central Ethiopia

open access: yesInternational Journal of Hypertension, 2020
Background Adherence to treatment is a primary determinant of treatment success. Nonadherence attenuates clinical benefits to the recipients of the treatment.
Daniel G/Tsadik, Y. Berhane, A. Worku
semanticscholar   +1 more source

Diuretics: again the first step in the treatment of most patients with hypertension

open access: yesCurrent Controlled Trials in Cardiovascular Medicine, 2001
The results and interpretations of the most recent controlled clinical trials on antihypertensive drugs have fuelled the debate about the drug that should be used to begin treatment for hypertension.
Fuchs Flávio
doaj   +1 more source

Antihypertensive treatment in the elderly

open access: yesSouth African Family Practice, 2011
No abstract available.
J.A. Ker
doaj   +1 more source

Antihypertensive Treatment in Elderly Frail Patients

open access: yesHYPERTENSION, 2020
Supplemental Digital Content is available in the text. Aim of our study was to assess the relationship between adherence with antihypertensive drugs and the risk of death in frail versus nonfrail old individuals. Using the database of the Lombardy Region
F. Rea   +5 more
semanticscholar   +1 more source

The Renin-Angiotensin System in the Development of Salt-Sensitive Hypertension in Animal Models and Humans

open access: yesPharmaceuticals, 2010
Hypertension is still one of the major causes of death from cardiovascular failure. Increased salt intake may aggravate the rise in blood pressure and the development of consequential damage of the heart, the vessels and other organs.
Beate Rassler
doaj   +1 more source

Comparative efficacy and safety of fimasartan in patients with hypertension: A network meta‐analysis of randomized controlled trials

open access: yesThe Journal of Clinical Hypertension, 2022
Hypertension is a prevalent risk factor for cardiovascular disease. Angiotensin II receptor blockers are widely prescribed to patients with hypertension, while new drugs are continuously developed.
Suk Min Seo   +4 more
doaj   +1 more source

Prescribing patterns and pharmacoeconomic analysis of antihypertensive drugs in South Indian population: A cross-sectional study

open access: yesPerspectives in Clinical Research, 2023
Background: Global evidence-based recommendations for hypertension management are periodically updated, and ensuring adherence to the guidelines is imperative.
S Shanmugapriya   +5 more
doaj   +1 more source

OPTIMIZING THE TREATMENT OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASE WITH LERCANIDIPINE

open access: yesРациональная фармакотерапия в кардиологии, 2015
Comorbidity of cardiovascular diseases reciprocally aggravates their course and induces the need to use safety and well-tolerated drugs. Pharmacological and pharmacokinetic properties of lercanidipine – the third-generation calcium channel blocker – are ...
E. L. Trisvetova
doaj   +1 more source

Sex-specific differences in hypertension

open access: yesРоссийский кардиологический журнал, 2023
The diagnosis of hypertension (HTN) has been known to doctors for many years. Current clinical guidelines represent a unified approach to the treatment and prevention of hypertension in patients of both sexes.
T. O. Brodovskaya, D. V. Kasyanov
doaj   +1 more source

The influence of sociodemographic factors on the use of antihypertensive drugs among adults in Serbia: Cross-sectional study [PDF]

open access: yesHospital Pharmacology, 2017
Background: Despite the knowledge that they have high blood pressure, which can be controlled with medicines, one portion of the patients still ignores doctor's advice.
Mihailović Nataša M.   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy